Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anaptysbio (ANAB) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for Anaptysbio (ANAB) over the last 11 years, with Q3 2025 value amounting to $353.1 million.

  • Anaptysbio's Liabilities and Shareholders Equity fell 2843.84% to $353.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 billion, marking a year-over-year decrease of 1038.68%. This contributed to the annual value of $483.8 million for FY2024, which is 695.09% up from last year.
  • Anaptysbio's Liabilities and Shareholders Equity amounted to $353.1 million in Q3 2025, which was down 2843.84% from $335.2 million recorded in Q2 2025.
  • In the past 5 years, Anaptysbio's Liabilities and Shareholders Equity registered a high of $643.1 million during Q4 2021, and its lowest value of $335.2 million during Q2 2025.
  • In the last 5 years, Anaptysbio's Liabilities and Shareholders Equity had a median value of $483.8 million in 2024 and averaged $488.3 million.
  • In the last 5 years, Anaptysbio's Liabilities and Shareholders Equity surged by 5770.5% in 2022 and then crashed by 2843.84% in 2025.
  • Quarter analysis of 5 years shows Anaptysbio's Liabilities and Shareholders Equity stood at $643.1 million in 2021, then fell by 5.08% to $610.4 million in 2022, then decreased by 25.88% to $452.4 million in 2023, then grew by 6.95% to $483.8 million in 2024, then dropped by 27.02% to $353.1 million in 2025.
  • Its last three reported values are $353.1 million in Q3 2025, $335.2 million for Q2 2025, and $422.1 million during Q1 2025.